Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Nycomed to acquire Bradley

Nycomed (Zurich, Switzerland) agreed to acquire dermatology company BDY for $20 per share, or $346 million in

Read the full 170 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE